Regulatory | Ophthalmology Innovation Source

Follow our social pages & join our growing community

Is pSivida on the verge of megastar status?

With three of the four sustained-release drug delivery products commercially available in the U.S. and Europe, pSivida just might prove Wall Street pundits correct and score some big wins in the ophthalmic space. The Watertown, Mass.-based company’s Durasert technology can deliver drugs to the posterior segment for a predetermined amount of time ranging from months…

Large Device Companies Eyeing Opportunities in Ophthalmic Space

NEW ORLEANS — The oft-repeated Cajun expression in this fun loving town, ”laissez les bon temps roulez,” translated as let the good times roll may be an accurate way of summarizing the upbeat mood at this year’s annual meeting of the American Academy of Ophthalmology (AAO; San Francisco). The AAO is by far the largest…